Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
106 hedge funds and large institutions have $686M invested in Taro Pharmaceutical Industries Ltd. in 2015 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 35 reducing their positions, and 12 closing their positions.
92% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 12
34% more call options, than puts
Call options by funds: $11.4M | Put options by funds: $8.49M
10% more funds holding
Funds holding: 96 → 106 (+10)
10% more funds holding in top 10
Funds holding in top 10: 10 → 11 (+1)
3% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 35
4% less capital invested
Capital invested by funds: $715M → $686M (-$28.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
+$5.55M |
| 2 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
+$4.99M |
| 3 |
AIIMS
Analyst IMS Investment Management Services
Tel-Aviv,
Israel
|
+$4.72M |
| 4 |
MICM
Matthews International Capital Management
San Francisco,
California
|
+$4.66M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
-$19.1M |
| 2 |
Millennium Management
New York
|
-$15M |
| 3 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$9.73M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$7.59M |
| 5 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$6.15M |
TARO Hedge Fund Activity: Q2 2015 in Review
106 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q2 2015, worth a combined $686M — down 4% from $715M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new TARO positions and 12 closed out — a net gain of 11 holders — while 36 added to existing stakes and 35 trimmed.
The largest buyer was Raging Capital Management, adding an estimated $5.55M. The largest seller was ISZO Capital Management, cutting an estimated $19.1M.
- 106 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q2 2015, up from 96 in Q1 2015.
- Funds reported $686M of Taro Pharmaceutical Industries Ltd. stock for Q2 2015, down 4% quarter-over-quarter.
- 23 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q2 2015 and 12 closed out, a net change of +11 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q2 2015 was Raging Capital Management, an estimated $5.55M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q2 2015 was ISZO Capital Management, an estimated $19.1M sold.
Based on aggregated 13F filings for Q2 2015.